This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kucharczyk, J. Articles by Norman, D. Search for Related Content PubMed PubMed Citation Articles by Kucharczyk, J. Articles by Norman, D.

Stroke, Vol 20, 268-274, Copyright © 1989 by American Heart Association

ARTICLES

Nicardipine reduces ischemic brain injury. Magnetic resonance imaging/spectroscopy study in cats

J Kucharczyk, W Chew, N Derugin, M Moseley, C Rollin, I Berry and D Norman
Department of Radiology, School of Medicine, University of California, San Francisco 94143.

We investigated whether the calcium channel entry blocker nicardipine would reduce ischemic brain damage in barbiturate-anesthetized cats subjected to permanent unilateral occlusion of the middle cerebral artery. The evolution of cerebral injury was assessed in vivo in 24 cats by a combination of proton magnetic resonance imaging and phosphorus-31 magnetic resonance spectroscopy for 5 hours following occlusion. Immediately thereafter, the volume of histochemically ischemic brain tissue was determined planimetrically in triphenyl tetrazolium chloride-stained serial coronal sections. Nicardipine was initially administered as an intravenous bolus injection of 10 mg/kg/hr 15 minutes before or 15 minutes after occlusion, followed by continuous infusion at 8 mg/kg/hr for the 5 hours of the experiment. Compared with untreated controls, cats that received nicardipine before or after occlusion showed a significant reduction in the extent of edema in the ipsilateral cerebral cortex, internal capsule, and basal ganglia. The results of phosphorus-31 magnetic resonance spectroscopy studies suggest that nicardipine may protect against cerebral ischemic damage by an action on cellular metabolic processes that preserve high-energy phosphates during the ischemic period.

This article has been cited by other articles:

				W. T. C. Yuh, T. Ueda, M. White, M. E. Schuster, and T. Taoka The Need for Objective Assessment of the New Imaging Techniques and Understanding the Expanding Roles of Stroke Imaging AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1779 - 1784. [Full Text]